Effects of Preoperative Embolization on Spetzler–Martin Grade I and II Arteriovenous Malformations: A Propensity-Adjusted Analysis

BACKGROUND: Cerebral arteriovenous malformations (AVMs) with low Spetzler–Martin grades (I and II) are associated with good neurological outcomes after microsurgical resection; however, the use of preoperative embolization for these lesions is controversial. OBJECTIVE: To compare the neurological outcomes of preoperative embolization with no embolization in patients with low-grade AVMs. METHODS: Patients with a Spetzler–Martin grade I or II AVM who underwent microsurgical resection during January 1, 1997, through December 31, 2019, were analyzed. Patients undergoing preoperative embolization were compared with patients not undergoing embolization. A propensity score was constructed from baseline characteristics and used to match intervention (embolization) and control (nonembolization) groups in a 1:1 ratio. The primary outcome was poor neurological status on last follow-up examination, defined as a modified Rankin Scale score >2 and a modified Rankin Scale score worse at follow-up than at the preoperative examination. RESULTS: Of the 603 patients analyzed, 310 (51.4%) underwent preoperative embolization and 293 (48.6%) did not. Patients in the embolization cohort compared with those in the nonembolization cohort had a higher percentage of Spetzler–Martin grade II AVMs (71.6% vs 52.6%, P < .001) and a lower percentage of hemorrhage (41% vs 55%, P = .001). After propensity score matching, no differences were found between paired cohorts (each N = 203) for baseline characteristics with a significant reduction in absolute standardized mean differences. No significant differences were found in primary outcomes between treatment groups in the matched or unmatched cohorts. CONCLUSION: Preoperative embolization of low-grade Spetzler–Martin AVMs is not associated with improved neurological outcomes after microsurgical resection.

[1]  M. Lawton,et al.  Spetzler-Martin Grade III Arteriovenous Malformations: A Multicenter Propensity-Adjusted Analysis of the Effects of Preoperative Embolization. , 2021, Neurosurgery.

[2]  C. McCulloch,et al.  The effect of preoperative embolization and flow dynamics on resection of brain arteriovenous malformations. , 2020, Journal of neurosurgery.

[3]  J. Mohr,et al.  Grades of brain arteriovenous malformations and risk of hemorrhage and death , 2019, Annals of clinical and translational neurology.

[4]  R. Tamargo,et al.  Assessing the Role of Preoperative Embolization in the Surgical Management of Cerebral Arteriovenous Malformations. , 2017, World neurosurgery.

[5]  M. Lawton,et al.  Current surgical results with low-grade brain arteriovenous malformations. , 2015, Journal of neurosurgery.

[6]  M. Morgan,et al.  The failure of preoperative ethylene-vinyl alcohol copolymer embolization to improve outcomes in arteriovenous malformation management: case series. , 2013, Journal of neurosurgery.

[7]  F. Ponce,et al.  A 3-tier classification of cerebral arteriovenous malformations. Clinical article. , 2011, Journal of neurosurgery.

[8]  G. Duckwiler,et al.  A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. , 2010, Journal of neurosurgery.

[9]  C. McCulloch,et al.  A Supplementary Grading Scale for Selecting Patients With Brain Arteriovenous Malformations for Surgery , 2010, Neurosurgery.

[10]  Brian Y. Hwang,et al.  Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations: Outcomes, Complications, and Predictors of Neurologic Deficits , 2009, Stroke.

[11]  P. Purdy,et al.  Preoperative Embolization of Cerebral Arteriovenous Malformations with Onyx , 2009, American Journal of Neuroradiology.

[12]  G. Tomlinson,et al.  Complications of embolization of arteriovenous malformations of the brain. , 2006, Journal of neurosurgery.

[13]  E. Connolly,et al.  Determinants of Staged Endovascular and Surgical Treatment Outcome of Brain Arteriovenous Malformations , 2005, Stroke.

[14]  C. Giller,et al.  Complications of preoperative embolization of cerebral arteriovenous malformations. , 2004, Journal of neurosurgery.

[15]  D. Nichols,et al.  N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. , 2002, AJNR. American journal of neuroradiology.

[16]  M. Morgan,et al.  Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain , 2000, Journal of Clinical Neuroscience.

[17]  W. Young,et al.  Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. , 1995, AJNR. American journal of neuroradiology.

[18]  P. Purdy,et al.  Arteriovenous malformations of the brain: choosing embolic materials to enhance safety and ease of excision. , 1992, Journal of neurosurgery.

[19]  P. Purdy,et al.  Intraarterial sodium amytal administration to guide preoperative embolization of cerebral arteriovenous malformations. , 1991, Journal of neurosurgical anesthesiology.

[20]  P. Purdy,et al.  Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: experience in 51 adults. , 1990, AJNR. American journal of neuroradiology.

[21]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[22]  C. McCulloch,et al.  Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. , 2015, Neurosurgery.

[23]  J. Swieten Interobserver Agreement for the Assessment of Handicap in Stroke Patients , 2005 .

[24]  M. Kupersmith,et al.  The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. , 1993, Journal of neurosurgery.

[25]  R F Spetzler,et al.  A proposed grading system for arteriovenous malformations. , 1986, Journal of neurosurgery.

[26]  D. Samson,et al.  Intravascular use of isobutyl 2-cyanoacrylate: Part 1 Treatment of intracranial arteriovenous malformations. , 1981, Neurosurgery.